Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin

Avis Dafa-Berger, Alona Kuzmina, Michael Fassler, Hila Yitzhak-Asraf, Yonat Shemer-Avni, Ran Taube

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Hepatitis C virus is a leading cause of chronic hepatitis and liver cancer. Little information exists on the interplay between innate defense mechanisms and viral antagonists that promote viral egress. Herein, the effects of Tetherin/BST-2 on HCV release were investigated. In Huh-7.5 hepatocytes, low expression levels of BST-2 were detected. Treatment of Huh-7.5 cells with IFNα, elevated BST-2 expression levels. However, HCV could not alter the expression of IFNα-induced BST-2, nor of stably over-expressed BST-2. Significantly, over expressed BST-2 moderately blocked HCV production and release from Huh-7.5 cells. Functional analysis of BST-2, confirmed its ability to inhibit the release of HIV delta-Vpu from Huh-7.5-BST-2 cells. HIV-Vpu antagonized BST-2 activity and rescued HIV delta-Vpu release from Huh-7.5-BST-2 cells. However, vpu slightly rescued HCV release and production from Huh-7.5-BST-2. We conclude that BST-2 moderately restricts HCV production and release from Huh-7.5 hepatocytes, while the virus lacks mechanisms to counteract this restriction.

Original languageEnglish
Pages (from-to)98-111
Number of pages14
Issue number2
StatePublished - 5 Jul 2012


  • BST-2/Tetherin
  • HIV vpu
  • Hepatitis C virus
  • IFN type I innate response
  • Viral release

ASJC Scopus subject areas

  • Virology


Dive into the research topics of 'Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin'. Together they form a unique fingerprint.

Cite this